PRESS-RELEASE filed Jul 31, 2026 at 06:00 ET
BrightSpring Health Services reported Q2 2026 revenue of $3,873M (+23% YoY) and GAAP diluted EPS from continuing ops of $0.39, a -2.1% miss vs consensus of $0.40. However, the company raised full-year 2026 revenue guidance to $15.1B-$15.425B and Adjusted EBITDA guidance to $820M-$845M, signaling strong operational momentum. The EPS miss is minor and overshadowed by the guidance raise, robust 44% Adjusted EBITDA growth, and a $300M debt paydown that reduced leverage to 2.15x, making this a net positive event for the stock.